Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
AFFF Lawsuit Exposure to firefighting foam chemicals may result in an increased risk of cancer for firefighters, military and airport personnel.
Nursing Home Neglect, Low Staffing, Helping To Spread Dangerous Drug-Resistant Infection: Report September 17, 2019 Irvin Jackson Add Your Comments Healthcare professionals are having trouble combating potentially deadly and often drug-resistant candida auris (C. auris) infections, due to nursing home neglect and staffing problems at facilities throughout the U.S., according to a new report. The New York Times published findings of an investigation last week, which detail how nursing home c. auris infections impacted 39 patients in just one Brooklyn facility, suggesting that the drug-resistant infection appears to be spreading rapidly due to poorly-run long-term care facilities. Candida auris is a fungus first seen in Japan in 2009, and came to the U.S. in 2015. Since it first arrived in the U.S., the infection has spread dramatically, especially at hospitals and nursing homes. Do You Know about… hair dye cancer lawsuits For Salon Professionals Hair dye lawsuits are being pursued for salon professionals who were routinely exposed to hair dye chemicals and diagnosed with bladder cancer or breast cancer. See if you qualify for a hair dye cancer lawsuit settlement. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… hair dye cancer lawsuits For Salon Professionals Hair dye lawsuits are being pursued for salon professionals who were routinely exposed to hair dye chemicals and diagnosed with bladder cancer or breast cancer. See if you qualify for a hair dye cancer lawsuit settlement. Learn More SEE IF YOU QUALIFY FOR COMPENSATION In an April report, the U.S. Centers for Disease Control and Prevention (CDC) warned that there were 587 confirmed cases, 30 probable cases, and more than 1,000 people who tested positive for candida auris colonization since 2016, meaning the fungus is living on their body but not making them ill. That number has increased to 800 confirmed cases, according to the New York Times report. In New York alone, there are 396 known infection cases, and nearly 500 people are known to be carriers who have not been infected. Half of infected patients die within 90 days, according to the report. The infections and carriers are also widespread in Chicago, among patients living on dedicated ventilator floors of nursing homes. The report indicates that while much of the blame for the spread of c. auris has been linked to overuse of antibiotics in the past, now attention is turning to nursing homes and long-term care facilities as major vectors for the spread of the infections. It has gotten so bad, that some facilities are refusing to accept patients with the infections. There are a number of reasons for the spread through these facilities, according to the report. Stopping its spread requires diligent infection control measures, which are difficult to maintain if facilities are understaffed or do not have the proper equipment. The situation is exacerbated as sick patients go back and forth from nursing homes to hospitals, increasing the odds they spread the infections every time. C. Auris Infection Concerns C.auris is not a threat to most healthy people. However, among those with weakened immune systems, the fungal infection can be serious and life threatening. Roughly 30-60% of people who get C. auris die within 90 days. However, many of those people were already sick with other conditions, which is what made them more susceptible to the infection. The fungus acts like a bacteria because it can stick to and live on surfaces in healthcare environments, including medical equipment, light switches, mattresses, bed rails, and the hands of doctors and healthcare staff. Infections begin with a fever and chills, which can make it hard to diagnose early. Most infections respond to echinocandins, a type of anti fungal medication. However, some strains are resistant to the main classes of drugs. This requires doctors to treat patients with multiple types of medication at much higher doses or all three classes of drugs at the same time. The CDC first warned the public about C. auris in 2017, as reports of the infection became more frequent, especially among hospitalized patients. As confirmed cases of the infection increased to more than 122 people, the CDC issued warnings regarding the danger C. auris poses to the country. Most cases in the U.S. were reported in New York City, New Jersey, and Chicago, but other states have also confirmed infections. Patients can follow certain precautions to prevent candida auris infections, including frequent hand washing and requesting their doctor wash hands before examining them. However, healthcare facilities must change the way they clean and disinfect patient rooms in order to prevent infections from spreading rapidly through hospitals. The CDC also recommends patients with C. auris be kept in the same room to prevent spreading it to other patients and to help keep extensive cleaning measures needed following C. auras infection to only certain rooms. Tags: Antibiotics, Bacterial Contamination, Candida Auris, Hospital Infections, Infection, Nursing Home, Nursing Home Neglect More Lawsuit Stories Four BioZorb Breast Tissue Marker Lawsuits Selected for Bellwether Trials April 2, 2025 Nitrous Oxide Class Action Lawsuit Filed Over Fatal Side Effects of Flavored Gas Sold In Vape Shops April 2, 2025 Artificial Stone Cutter Files Lawsuit Over Silicosis Lung Disease April 2, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Four BioZorb Breast Tissue Marker Lawsuits Selected for Bellwether Trials (Posted: yesterday) As new BioZorb lawsuits continue to be filed over complications with the recalled breast tissue markers, lawyers indicate they are on track for the first of four test cases to go before a jury in September 2025. MORE ABOUT: BIOZORB LAWSUITCourt Clears BioZorb Lawsuit Design Defect Claims Over Recalled Breast Tissue Marker (03/26/2025)Group of 7 BioZorb Injury Lawyers Appointed to Leadership Positions in Lawsuits Over Recalled Breast Tissue Marker (03/19/2025)Breast Cancer Survivors File Lawsuit Over Recalled BioZorb Tissue Marker (03/12/2025) Depo-Provera Meningioma Diagnosis Information Required To Qualify for Lawsuit: Order (Posted: 2 days ago) Women pursuing Depo-Provera meningioma lawsuits will have to provide documentary proof of their diagnosis and the versions of the birth control shot they received within 120 days of filing their case. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Lawsuit Timeline for Preparing Pilot Trial Cases Outlined by MDL Judge (03/24/2025)Women Can File Depo-Provera Brain Tumor Lawsuits Directly in MDL: Court Order (03/18/2025)75 Lawyers in Depo-Provera Lawsuits Seek MDL Leadership Roles (03/10/2025) Cartiva SCI Lawsuit Alleges Toe Implant Worsened Pain, Decreased Range of Motion (Posted: 3 days ago) An Indiana woman has filed a Cartiva SCI implant lawsuit, indicating that the toe implant failed due to a defective design, resulting in the need for revision surgery and recommendations to permanently fuse her big toe. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Implant Injury Lawsuit Set for Trial in February 2026 (03/07/2025)Lawsuit Indicates Cartiva Implant Fails in 2 Out of 3 Patients, But Continued To Be Sold in U.S. (02/13/2025)Cartiva Toe Implant Lawsuit Filed Over Worsened Pain, Reduced Range of Motion and Need for Surgical Removal (02/07/2025)
Nitrous Oxide Class Action Lawsuit Filed Over Fatal Side Effects of Flavored Gas Sold In Vape Shops April 2, 2025
Four BioZorb Breast Tissue Marker Lawsuits Selected for Bellwether Trials (Posted: yesterday) As new BioZorb lawsuits continue to be filed over complications with the recalled breast tissue markers, lawyers indicate they are on track for the first of four test cases to go before a jury in September 2025. MORE ABOUT: BIOZORB LAWSUITCourt Clears BioZorb Lawsuit Design Defect Claims Over Recalled Breast Tissue Marker (03/26/2025)Group of 7 BioZorb Injury Lawyers Appointed to Leadership Positions in Lawsuits Over Recalled Breast Tissue Marker (03/19/2025)Breast Cancer Survivors File Lawsuit Over Recalled BioZorb Tissue Marker (03/12/2025)
Depo-Provera Meningioma Diagnosis Information Required To Qualify for Lawsuit: Order (Posted: 2 days ago) Women pursuing Depo-Provera meningioma lawsuits will have to provide documentary proof of their diagnosis and the versions of the birth control shot they received within 120 days of filing their case. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Lawsuit Timeline for Preparing Pilot Trial Cases Outlined by MDL Judge (03/24/2025)Women Can File Depo-Provera Brain Tumor Lawsuits Directly in MDL: Court Order (03/18/2025)75 Lawyers in Depo-Provera Lawsuits Seek MDL Leadership Roles (03/10/2025)
Cartiva SCI Lawsuit Alleges Toe Implant Worsened Pain, Decreased Range of Motion (Posted: 3 days ago) An Indiana woman has filed a Cartiva SCI implant lawsuit, indicating that the toe implant failed due to a defective design, resulting in the need for revision surgery and recommendations to permanently fuse her big toe. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Implant Injury Lawsuit Set for Trial in February 2026 (03/07/2025)Lawsuit Indicates Cartiva Implant Fails in 2 Out of 3 Patients, But Continued To Be Sold in U.S. (02/13/2025)Cartiva Toe Implant Lawsuit Filed Over Worsened Pain, Reduced Range of Motion and Need for Surgical Removal (02/07/2025)